Cargando…
Virus–host interactomes — antiviral drug discovery
One of the key questions in virology is how viruses, encoding relatively few genes, gain temporary or constant control over their hosts. To understand pathogenicity of a virus it is important to gain knowledge on the function of the individual viral proteins in the host cell, on their interactions w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102765/ https://www.ncbi.nlm.nih.gov/pubmed/23057872 http://dx.doi.org/10.1016/j.coviro.2012.09.003 |
_version_ | 1783511904441860096 |
---|---|
author | Ma-Lauer, Yue Lei, Jian Hilgenfeld, Rolf von Brunn, Albrecht |
author_facet | Ma-Lauer, Yue Lei, Jian Hilgenfeld, Rolf von Brunn, Albrecht |
author_sort | Ma-Lauer, Yue |
collection | PubMed |
description | One of the key questions in virology is how viruses, encoding relatively few genes, gain temporary or constant control over their hosts. To understand pathogenicity of a virus it is important to gain knowledge on the function of the individual viral proteins in the host cell, on their interactions with viral and cellular proteins and on the consequences of these interactions on cellular signaling pathways. A combination of transcriptomics, proteomics, high-throughput technologies and the bioinformatical analysis of the respective data help to elucidate specific cellular antiviral drug target candidates. In addition, viral and human interactome analyses indicate that different viruses target common, central human proteins for entering cellular signaling pathways and machineries which might constitute powerful broad-spectrum antiviral targets. |
format | Online Article Text |
id | pubmed-7102765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71027652020-03-31 Virus–host interactomes — antiviral drug discovery Ma-Lauer, Yue Lei, Jian Hilgenfeld, Rolf von Brunn, Albrecht Curr Opin Virol Article One of the key questions in virology is how viruses, encoding relatively few genes, gain temporary or constant control over their hosts. To understand pathogenicity of a virus it is important to gain knowledge on the function of the individual viral proteins in the host cell, on their interactions with viral and cellular proteins and on the consequences of these interactions on cellular signaling pathways. A combination of transcriptomics, proteomics, high-throughput technologies and the bioinformatical analysis of the respective data help to elucidate specific cellular antiviral drug target candidates. In addition, viral and human interactome analyses indicate that different viruses target common, central human proteins for entering cellular signaling pathways and machineries which might constitute powerful broad-spectrum antiviral targets. Elsevier B.V. 2012-10 2012-10-09 /pmc/articles/PMC7102765/ /pubmed/23057872 http://dx.doi.org/10.1016/j.coviro.2012.09.003 Text en Copyright © 2012 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ma-Lauer, Yue Lei, Jian Hilgenfeld, Rolf von Brunn, Albrecht Virus–host interactomes — antiviral drug discovery |
title | Virus–host interactomes — antiviral drug discovery |
title_full | Virus–host interactomes — antiviral drug discovery |
title_fullStr | Virus–host interactomes — antiviral drug discovery |
title_full_unstemmed | Virus–host interactomes — antiviral drug discovery |
title_short | Virus–host interactomes — antiviral drug discovery |
title_sort | virus–host interactomes — antiviral drug discovery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102765/ https://www.ncbi.nlm.nih.gov/pubmed/23057872 http://dx.doi.org/10.1016/j.coviro.2012.09.003 |
work_keys_str_mv | AT malaueryue virushostinteractomesantiviraldrugdiscovery AT leijian virushostinteractomesantiviraldrugdiscovery AT hilgenfeldrolf virushostinteractomesantiviraldrugdiscovery AT vonbrunnalbrecht virushostinteractomesantiviraldrugdiscovery |